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The Arg-Gly-Asp (RGD) triplet found in the G-H loop of capsid protein VP1 of foot-and-mouth disease virus (FMDV) is
critically involved in the interaction of FMDV with integrin receptors and with neutralizing antibodies. Multiplication of FMDV
C-S8c1 in baby hamster kidney 21 (BHK-21) cells selected variant viruses exploiting alternative mechanisms of cell
recognition that rendered the RGD integrin-binding triplet dispensable for infectivity. By constructing chimeric viruses, we
show that dispensability of the RGD in these variant FMDVs can be extended to surrounding amino acid residues.
Replacement of eight amino acid residues within the G-H loop of VP1 by an unrelated FLAG marker yielded infectious virus.
Evolution of FLAG-containing viruses in BHK-21 cells generated complex quasispecies in which individual mutants included
amino acid replacements at other antigenic sites of FMDV. Inclusion of such replacements in the parental FLAG clone
resulted in an increase of relative fitness of the viruses. These results suggest structural or functional connections between
antigenic sites of FMDV and underscore the value of mutant spectrum analysis for the identification of fitness-promoting
genetic modifications in viral populations. The possibility of producing viable viruses lacking antigenic site A may find
application in the design of new anti-FMD vaccines. © 2001 Academic Press
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cINTRODUCTION
Many viruses show some overlap between receptor–
recognition and antibody-binding sites (Stewart and
Nemerow, 1997; Baranowski et al., 2001). This suggests
that antigenic variation at these particular sites may be
restricted by the structural constraints imposed by virus–
receptor interaction. Work with foot-and-mouth disease
virus (FMDV) has documented that RNA viral quasispe-
cies harbor the evolutionary potential to overcome such
limitations and explore new antigenic structures upon
the acquisition of alternative mechanisms of cell recog-
nition (Mason et al., 1994; Martı´nez et al., 1997; Ruiz-
Jarabo et al., 1999; Baranowski et al., 2000b). The capac-
ity of FMDV and of many other RNA viruses to use
multiple cell surface molecules as receptors or corecep-
tors (Wimmer, 1994; Evans and Almond, 1998; Schneider-
Schaulies, 2000; Baranowski et al., 2001) may have im-
portant consequences for the evolution of viral antigenic
structures.
Recognition of integrin receptors by FMDV is mediated
by the mobile and protruding G-H loop of capsid protein
VP1, which includes an Arg-Gly-Asp (RGD) integrin-bind-
ing motif (Acharya et al., 1989; Fox et al., 1989; Berinstein
et al., 1995; Neff et al., 1998; Jackson et al., 2000a,b;
reviewed in Sobrino et al., 2001). The G-H loop of VP1t
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192also includes a major antigenic site for the virus, which
for FMDV of serotype C has been termed antigenic site
A (Mateu, 1995). Structural and functional studies have
shown that the RGD, and in particular the Asp residue, is
critical for both the interaction with integrins (Mateu et
al., 1996; Leippert et al., 1997) and the interaction with
site A-specific neutralizing antibodies (Verdaguer et al.,
1995, 1996, 1998). Antibodies directed to antigenic site A
are important determinants of protection against infec-
tion (Bittle et al., 1982; Pfaff et al., 1982; Strohmaier et al.,
1982; DiMarchi et al., 1986). An analysis of 19 sera from
convalescent or vaccinated swine revealed that on aver-
age, 57 or 27%, respectively, of the FMDV neutralizing
activity was directed to antigenic site A (Mateu et al.,
1995a). Despite its involvement in interactions with anti-
bodies, the RGD triplet is highly conserved among nat-
ural isolates of FMDV (Domingo et al., 1992; Mateu et al.,
1995b; Knowles and Palmenberg, 1998), probably reflect-
ing constraints imposed by the interaction with integrin
receptors in vivo (Neff et al., 1998). However, serial pas-
sages of FMDV in baby hamster kidney 21 (BHK-21) cells
rendered dispensable the RGD (Martı´nez et al., 1997;
Neff et al., 1998; Baranowski et al., 2000b), and several
mutants with replacements at this triplet that displayed
profound antigenic variations were isolated (Martı´nez et
al., 1997; Ruiz-Jarabo et al., 1999). Adaptation of FMDV to
ell culture selected for mutant viruses capable of using
he proteoglycan heparan sulfate (HS) as an alternative
eceptor (Jackson et al., 1996; Sa-Carvalho et al., 1997;
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193FMDV LACKING THE VP1 G-H LOOPNeff et al., 1998; Fry et al., 1999; Baranowski et al.,
2000b). When FMDV C-S8c1—a clone derived from a
natural isolate, FMDV C-Sta Pau Sp/70 (Sobrino et al.,
1983)—was passaged 100 or 213 times in BHK-21 cells,
the virus acquired the potential to enter BHK-21 cells
through the interaction with multiple receptors including
integrins, HS, and a third, unidentified cell surface mol-
ecule (Baranowski et al., 2000b).
In addition to site A, two main neutralization sites have
been described for FMDV C-S8c1, the carboxy-terminal
region of VP1, termed site C, and a discontinuous site
termed site D (Fig. 1). The study of binding of monoclonal
antibodies (MAbs) to synthetic peptides representing
surface domains of the viral capsid, and the location of
amino acid replacements in MAb escape mutants, de-
fined the carboxy-terminal region of VP1 as a continuous
antigenic site, structurally independent of site A (Lea et
al., 1994; Mateu et al., 1994). The complex, discontinuous
site D was characterized as involving residues of the
carboxy-terminus of VP1, the BC loop of VP2, and the BB
knob of VP3 (Lea et al., 1994). At least four independent
sites have been mapped on the structure of serotype O
FMDV (Acharya et al., 1989; Kitson et al., 1990; Mateu,
1995). In this serotype, several amino acid residues at
the G-H loop and at the C-terminus region of capsid
protein VP1 are part of the conformational antigenic site
1; sites 2, 3, and 4 involve loops of capsid proteins VP2,
VP1, and VP3, respectively. Finally, multiple sites have
FIG. 1. Scheme of the location of antigenic sites in structural proteins
box, as defined by the location of amino acid substitutions in MAb escap
1995, Mateu et al., 1994, and references therein). Sites not specifical
dentified in FMDV A12 (Baxt et al., 1989). The locations of antigenic site
cid residue numbering for the individuals capsid proteins refers to F
elative site locations are not drawn to scale). The secondary structure
re indicated (Acharya et al., 1989); they include the C-terminus (Ct) of V
re located close to a loop, the corresponding loop is indicated. Secon
elow the G-H loop of VP1, the amino acid sequence of antigenic site
ntegrin-binding triplet is underlined.been identified in different subtypes of FMDV of serotype
A, as summarized in Fig. 1 (reviewed in Mateu, 1995).The purpose of the present study was to test the
capacity of FMDV to tolerate an extremely drastic alter-
ation at antigenic site A, consisting not merely of amino
acid substitutions within the RGD (Martı´nez et al., 1997;
Ruiz-Jarabo et al., 1999), but of the absence of the RGD
and surrounding amino acids. Recombinant FMDVs ex-
pressing a DYKDDDDK octapeptide in place of eight
amino acids spanning the integrin receptor-binding re-
gion of VP1 G-H loop were constructed. The octapeptide
sequence DYKDDDDK, also termed FLAG marker se-
quence, is an antigenic structure that can be readily
detected by specific antibodies (Prickett et al., 1989). The
results indicate that FMDVs that display RGD-indepen-
dent mechanisms of cell recognition can replicate in
BHK-21 cells despite the absence of antigenic site A.
Evolution of FLAG-containing FMDVs in BHK21 cells re-
vealed interactions of the VP1 G-H loop region with other
antigenic sites, identified through sampling of the mutant
spectra of FLAG-FMDV quasispecies.
RESULTS
Antigenic site A is not required for FMDV infectivity
The full-length cDNAs of FMDV O1K expressing the
capsid of C-S8c1 and of two cell culture-adapted deriv-
atives C-S8c1p100 and C-S8c1p213 (Baranowski et al.,
2000b) were used to construct FMDV particles lacking
antigenic site A (Fig. 2). Chimeric FMDVs O1K/p100 and
DV of serotypes O, A, and C. Antigenic sites are indicated in the upper
nts of FMDV O1Kaufbeuren, O1BFS, A10, and C-S8c1 (based on Mateu,
ed in the original references are given in parentheses. Site (4)* was
sid proteins VP1, VP2, and VP3 are indicated by gray boxes. The amino
-S8c1 (Toja et al., 1999) (boxes representing VP1, VP2, and VP3 and
ts of FMDV capsid proteins in which the antigenic sites were identified
surface-exposed loops of VP1, VP2, and VP3. When antigenic residues
ructure assignments are as in Mateu et al. (1994) and Lea et al. (1994).
nd in FMDV C-S8c1 is indicated (VP1 residues 136 to 151). The RGDof FM
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194 BARANOWSKI ET AL.pacity to enter BHK-21 cells via RGD-independent path-
ways (Baranowski et al., 2000b). In each construct, the
ucleotide sequence corresponding to VP1 G-H loop
mino acid residues 139 to 146 was replaced by a se-
uence encoding the FLAG marker (Prickett et al., 1989).
FMDV cDNAs encoding the FLAG marker are designated
pO1K/C-S8c1F, pO1K/p100F, and pO1K/p213F (Fig. 2).
Infectious virus progeny were produced upon electropo-
ration of BHK-21 with RNA transcripts derived from plas-
mids pO1K/p100F and pO1K/p213F, but not with RNA
from pO1K/C-S8c1F. Particles produced by recombinant
FMDVs O1K/p100F and O1K/p213F were recognized by
anti-FLAG antibodies, as documented by direct ELISA
and Western blot assays (Fig. 3). Conversely, site A-spe-
cific monoclonal antibody SD6 (Mateu et al., 1989) re-
cted with viruses O1K/p100 and O1K/p213 and not with
heir FLAG derivatives O1K/p100F and O1K/p213F (Fig.
). These results indicate that capsid substitutions in
FIG. 2. Amino acid replacements in the exposed capsid proteins of
of serotype C was inserted into the full-length cDNA of FMDV O1K (Zibe
of serotypes O and C analyzed here, is not represented. Numbers refe
al., 1999). The origin of the viruses used for construction of chimeric cD
and the confirmatory nucleotide sequence analysis of virus progeny are
indicate the chimeras containing the capsid of the parental FMDV C-S8
in BHK-21 cells (Martı´nez et al., 1997; Baranowski et al., 1998); F indica
Boldface letters denote amino acid replacements relative to the seque
FIG. 3. Western blot analysis of chimeric FMDV particles. Capsid pro
t al., 1990) and anti-FLAG polyclonal antibodies (Prickett et al., 1989).
escribed in the text. Concentration of viral particles, protein sepa
embranes, and reactions with antibodies are described under Materials and
ot shown).FMDV C-S8c1 that rendered viral infectivity independent
of the presence of the RGD integrin-binding motif re-
duced drastically the structural constraints at the G-H
loop of VP1 to the point of allowing FMDV replication in
the absence of antigenic site A.
Rapid adaptation of FLAG-containing FMDVs upon
replication in BHK-21 cells
Recombinant viruses O1K/p100F and O1K/p213F,
which express the FLAG sequence, showed reduced
replication capacity in BHK-21 cells when compared with
the corresponding parental viruses containing site A, as
evidenced by a 5- to 10-fold lower progeny production at
complete cytopathic effect (8 h postinfection) (Fig. 4).
After eight serial passages in BHK-21 cells [at a multi-
plicity of infection (m.o.i.) of 1 to 10 plaque-forming units
(PFU) per cell], FLAG-containing FMDVs exhibited im-
c FMDVs. The genomic region encoding the capsid proteins of FMDV
1990; Baranowski et al., 1998). VP4, which is conserved among FMDVs
corresponding positions in each individual protein of C-S8c1 (Toja et
e procedures employed for cDNA synthesis, and plasmid preparation,
d under Materials and Methods. O1K/C-S8c1, O1K/p100, and O1K/p213
rino et al., 1983) and C-S8c1 passaged 100 and 213 times, respectively,
presence of the FLAG marker instead of VP1 G-H residues 139 to 146.
the parental O1K/C-S8c1.
1 was detected using site A-specific monoclonal antibody SD6 (Mateu
are labeled to indicate the different chimeric FMDV variants tested as
by SDS–polyacrylamide gel electrophoresis, transfer of proteins tochimeri
rt et al.,
r to the
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195FMDV LACKING THE VP1 G-H LOOPproved replication efficiency with levels of infectious
progeny production similar to those of site A-positive
viruses (Fig. 4). In order to identify the genetic lesions
accumulated upon adaptation of FLAG-FMDVs to BHK-21
cells, the consensus nucleotide sequence of the entire
capsid-coding region of FMDVs O1K/p100F and O1K/
p213F at passage 8 (p8) was determined. FMDV O1K/
p100Fp8 RNA displayed nucleotide sequence heteroge-
neity at the FLAG-coding region, which did not allow the
determination of the consensus sequence between nu-
cleotides 3630 and 3643. To determine the extent of
heterogeneity and the distribution of sequences at the
VP1 G-H loop region, 20 biological clones were isolated
from population O1K/p100Fp8 and analyzed by sequenc-
ing of the genomic region encoding the G-H loop and the
C-terminus of VP1 (FMDV genomic positions 3573 to
3834) (Fig. 5). A deletion affecting three or five amino
acids within the FLAG marker was present in 40% of
clones isolated from FMDV O1K/p100Fp8, thus contrib-
uting to the ambiguities observed in the sequencing
peak pattern of the average O1K/p100Fp8 population. For
FMDV O1K/p213Fp8, no mutation could be found within
the entire consensus nucleotide sequence of the capsid-
coding region. However, the mutant spectrum of FMDV
O1K/p213Fp8 revealed the presence of viral genomes
encoding a number of alterations in VP1, including amino
acid substitutions and a deletion within the FLAG se-
quence (Fig. 5). Remarkably, several mutations mapped
outside the FLAG marker region and affected two differ-
ent positions of the VP1 capsid protein, corresponding to
antigenic site C (Q200 3 R and Q200 3 K) and the H-I
FIG. 4. Single-step production of chimeric FMDVs in BHK-21 cells. C
ndicated viruses expressing the capsid of C-S8c1p100 or C-S8c1p213
imes after infection, samples were taken for titration of infectivity o
epresents the mean of triplicate assays. Standard deviations are indic
escribed under Materials and Methods.loop (E167 3 K), which was described as antigenic for
MDV of serotype O (Kitson et al., 1990; Mateu, 1995)(Fig. 5). No additional mutations were found when the
analysis of the mutant spectrum of FMDV O1K/p213Fp8
was extended to the region encoding the amino-termi-
nus of VP2 (Fig. 5). The mutation frequencies in the
mutant spectra of O1K/p100Fp8 and O1K/p213Fp8 were
3.8 3 1024 and 2.8 3 1024 substitutions per nucleotide,
respectively (counting deletions as single mutations).
Distant antigenic sites of FMDV can be influenced by
the altered VP1 G-H loop
Since replacements at antigenic sites other than site A
are rare upon passage of FMDV C-S8c1 in BHK-21 cells
in the absence of antibodies (Dı´ez et al., 1989; Holguı´n et
al., 1997; Arias et al., 2001), the presence of replace-
ments in antigenic site C and the H-I loop of VP1 in the
mutant spectrum of O1K/p213Fp8 suggested a connec-
tion between the FLAG region and other antigenic sites
for fitness gain. To test this possibility, VP1 mutations
encoding replacements D1423 N, E1673 K, Q2003 R,
and Q200 3 K, or the deletion affecting codons 143 to
145, of VP1—found in the mutant spectrum of FMDV
O1K/p213Fp8 (Fig. 5)—were introduced in FMDV O1K/
p213F. The modified O1K/p213F viruses manifested a 5-
to 100-fold increase in production of infectious virus (Fig.
6). With each individual modification, replication capacity
of the recombinant virus in BHK-21 cells approached that
of the O1K/p213Fp8 population. No increase in virus
production was observed with the introduction of VP1
replacement E-167 3 K in O1K/p213F. To test in a more
stringent assay whether this replacement had any effect
olayers were infected (2 3 106 cells at a m.o.i. of 2 PFU/cell) with the
eir FLAG derivatives at passages 1 and 8 in BHK-21 cells. At different
21 cell monolayers, as described (Sobrino et al., 1983). Each value
he origin of FMDV chimeras and procedures for infection assays areell mon
and th
n BHK-on the infectivity of O1K/p213F, growth-competition ex-
periments were performed by coinfection of BHK-21 cells
s for bi
s
o
w
l
n
M
196 BARANOWSKI ET AL.with O1K/p213F and O1K/p213F K167. In this fitness as-
say (Holland et al., 1991), which is described in detail
under Materials and Methods, the progeny of the first
coinfection are used to infect fresh BHK-21 cells, and the
process is repeated a total of three times. The logarithm
FIG. 5. Mutant spectrum of FMDV O1K/p100Fp8 and O1K/p213Fp8
O1K/p213F at passage 8 in BHK-21 cells, and their genome was analyz
clones spans FMDV genomic positions 3574 to 3834 (VP1 amino acid r
C-terminus of VP1. For O1K/p213Fp8, the genomic region analyzed wa
amino acid residues A65 in VP2 to L209 in VP1). The positions where a
are indicated together with the number of biological clones including e
residue numbering refers to FMDV C-S8c1 (Toja et al., 1999). Procedure
equence determination are described under Materials and Methods.
FIG. 6. Effect of alterations of capsid protein VP1 on virus production b
f infection of 2 PFU per cell with chimeric FMDVs containing the indic
ith 0.1 M phosphate buffer (pH 6.0), and viral titers in the supernatan
east two determinations; variations in titer between the two determina
omenclature for the variant viruses, electroporation of BHK-21 cells with
aterials and Methods.of the proportion of the two viruses in the different pas-
sages is plotted as a function of the passage number,
and the antilogarithm of the slope is the relative fitness of
the two competing viruses. It must be emphasized that
these values represent fitness ratios (not fitness differ-
ty biological clones were isolated from populations O1K/p100F and
nucleotide sequencing. The genomic region analyzed in O1K/p100Fp8
H123 to L209), which span the region encoding the G-H loop and the
ded to the N-terminal region of VP2 (genomic positions 2089 to 3834;
(dash) or a nonsynonymous mutation (amino acid residue) was found
uence. Secondary structure motifs in VP1 are shown. The amino acid
ological cloning, RT-PCR amplification of genomic RNA, and nucleotide
V O1K/p213F. BHK-21 cells (2 3 106 cells) were infected at a multiplicity
odifications. After 1 h of adsorption at 37°C, monolayers were washed
determined at 2 and 4 h postinfection. Each value is the average of at
ever exceeded 30%. Procedures for construction of chimeric viruses,. Twen
ed by
esidues
s exten
deletion
ach seqy FMD
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197FMDV LACKING THE VP1 G-H LOOPences) and that as such they are dimensionless, relative
fitness values (Holland et al., 1991; Duarte et al., 1992;
Escarmı´s et al., 1996, 1999; Arias et al., 2001). A fitness of
3.1 (r 2 5 0.84) was measured for the chimera with
E1673 K relative to the parental chimera (the proportion
f O1K/p213F K167 relative to O1K/p213F was 0.67, 0.48,
.12, and 14.7 at passages 0, 1, 2, and 3, respectively). For
utants O1K/p213F K200, O1K/p213F R200, and O1K/
213F D143–145 the fitness relative to O1K/p213F was
arger than 9 in all cases. Therefore, adaptive changes in
he capsid of FMDV in which antigenic site A has been
eplaced by the FLAG marker can be directed to other
ntigenic sites of the virus, suggesting some functional
r structural interactions between antigenic sites of the
MDV capsid.
DISCUSSION
Cell recognition by FMDV can be mediated by both
GD-dependent and RGD-independent interactions with
ell surface components (reviewed in Sobrino et al.,
001), and integrins are probably the major class of
eceptor molecule employed by FMDV in vivo (Neff et al.,
998). Cell culture-adapted FMDV has been shown to
se heparan sulfate (HS) as an integrin-independent
eceptor (Jackson et al., 1996; Sa-Carvalho et al., 1997;
eff et al., 1998). Interestingly, FMDV clone C-S8c1 ac-
uired a third, RGD-independent and HS-independent
echanism of cell entry upon extensive passage in
HK-21 cells (Baranowski et al., 2000b).
Since RGD is a key part of several epitopes recognized
y neutralizing antibodies (Verdaguer et al., 1995, 1996,
997, 1998; Hewat et al., 1997; Ochoa et al., 2000), dis-
ensability of the RGD triplet for cell entry greatly ex-
anded the repertoire of antigenic variants of FMDV with
ubstitutions within antigenic site A (Martı´nez et al., 1997;
uiz-Jarabo et al., 1999). FMDV C-S8c1p100 harboring
ED, RGG, or even GGG instead of the RGD at VP1
ositions 141 to 143 was isolated and produced nearly
ormal yields of infectious progeny (Martı´nez et al., 1997;
uiz-Jarabo et al., 1999). It was interesting to explore
hether dispensability of the RGD triplet could be ex-
ended to surrounding amino acid residues and whether
he bulk of the loop could be occupied by unrelated
mino acids. To this end, loop residues 139 to 146 were
eplaced by the FLAG marker, a negatively charged
mino acid stretch used as an immunodetection tag for
xpressed proteins (Prickett et al., 1989) (Fig. 2). Results
f infectivity with this construct (Figs. 4 and 6) indicate
hat the capsid substitutions found in multiply passaged
MDV C-S8c1 (Martı´nez et al., 1997; Baranowski et al.,
998) not only permit point substitutions within the RGD,
ut allow unrelated sequences to take the place of loop
esidues.
Whole-virus, inactivated vaccines were instrumental
or the control of FMD in many world areas (Bahnemann,
(
c975; Barteling and Vreeswijk, 1991; Brown, 1995; So-
rino et al., 2001). However, some European FMD out-
reaks were associated with vaccine strains (Beck and
trohmaier, 1987; Sobrino et al., 2001), presumably due
ither to incomplete inactivation of infectivity or to es-
ape of virus from vaccine factories. In view of the re-
mergence of FMD in several Asian and European coun-
ries (Knowles et al., 2001), the nonvaccination policy
mplemented in the European Union since 1991 (Sobrino
t al., 2001) could be reconsidered. If new vaccines were
eeded, site A-negative FMDVs (or similar viruses de-
ective in integrin recognition), which can be produced in
arge amounts in cell culture, could be the basis of an
nactivated vaccine. If the virus were noninfectious in
ivo or highly attenuated for the natural hosts of FMDV,
angers inherent to handling of live virus or its incom-
lete inactivation would be greatly diminished, while
reserving the capacity to distinguish infected from vac-
inated animals (Shen et al., 1999; Sobrino et al., 2001),
hich is important for economic considerations (Sobrino
nd Domingo, 2001). The efficacy of such a vaccine
ould depend on the influence of antibodies directed
oward site A relative to antibodies directed to other
ntigenic sites (Mateu et al., 1994, 1995a, 1995b) on
rotection. The possibility that FLAG-FMDV (or related
himeric viruses) could be either noninfectious or highly
ttenuated in vivo rests largely on the generalized use of
ntegrins by FMDV during natural infections (Neff et al.,
998). It is intriguing, however, that substitutions within
he RGD or at neighboring positions thought to be in-
olved in integrin recognition were present in virus from
esions developed in partially immune cattle challenged
ith virulent FMDV (Taboga et al., 1997). Obviously, the
nown flexibility of receptor usage manifested by FMDV
n cell culture (reviewed in Baranowski et al., 2001) en-
ourages research on possible use of alternative recep-
ors by FMDV in vivo. Studies on infectivity, antigenicity,
nd immunogenicity of FLAG-FMDV are now in progress.
Eight serial passages of O1K/p100F and O1K/p213F in
HK-21 cells resulted in virus populations that showed a
- to 10-fold higher capacity to produce infectious prog-
ny than the parental viruses (Figs. 4 and 6). The con-
ensus nucleotide sequence of genomic residues 2089
o 3834 of O1K/p213Fp8 did not differ from that of its
arental O1K/p213F. Yet the mutant spectrum of O1K/
213Fp8 revealed individual genomes with mutations
ffecting antigenic sites of FMDV (Fig. 5). Fitness of
MDV O1K/p213F increased following the introduction of
hese capsid alterations into the O1K/p213F cDNA (Fig.
). These results suggest that the antigenic modifica-
ions found in the mutant spectrum of O1K/p213Fp8 ex-
rted some compensatory effect on O1K/p213F, perhaps
riginating from the mobility of the FMDV loop and its
ossible interactions with other surface capsid residuesLogan et al., 1993; Hewat et al., 1997). Analyses by
ryoelectron microscopy have shown that the loop of
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198 BARANOWSKI ET AL.C-S8c1 can occupy different positions when complexed
with two MAbs that recognize different site A epitopes
(Hewat et al., 1997; Verdaguer et al., 1999). Therefore,
particular loop positions may prompt interactions be-
tween certain amino acid residues of the VP1 G-H loop
and other capsid regions, contributing to direct or indi-
rect influences between site A and other antigenic sites.
In FMDV of serotype O, a connection between the VP1
G-H loop and the B-C loop of VP1 was proposed as the
basis of a new mechanism of antigenic variation of
FMDV (Parry et al., 1990). Further evidence for long-
distance interactions among capsid residues has been
reported for FMDV (Krebs et al., 1993) and other picor-
naviruses (Filman et al., 1989). An alternative nonexclu-
sive model is that the capsid replacements in
C-S8c1p100 and C-S8c1p213 (Martı´nez et al., 1997; Ruiz-
Jarabo et al., 1999) could alter the capsid structure in
such a way that antigenic sites are more proximal than in
the structure of C-S8c1 (Lea et al., 1994). Structural and
biochemical evidence with FMDV C-S8c1 (Lea et al.,
1994; Mateu et al., 1994; Mateu, 1995) suggests that in
this virus the G-H loop and the carboxy-terminal region of
VP1 define separate antigenic sites, whereas these two
domains of FMDV type O are part of a single functional
site (Acharya et al., 1989; Kitson et al., 1990; Mateu,
1995). Finally, it is also possible that alternative RGD-
independent mechanisms of cell recognition by FMDV
might be influenced by the amino acid sequence context
present at the G-H loop of VP1 (Baranowski et al., 1998)
and that mutations within the FLAG marker or at distant
regions of the capsid are selected to improve virus–
receptor interactions. The available functional and struc-
tural evidence does not favor any one of these several
possibilities.
Overlap between antigenic and receptor binding sites
in FMDV is not restricted to only the VP1 G-H loop.
Capsid surface modifications that are associated with
FMDV acquisition of RGD-independent mechanisms of
cell recognition map frequently at antigenic sites
(Sa-Carvalho et al., 1997; Baranowski et al., 1998; Fry et
al., 1999). Evidence of coevolution of receptor usage and
antigenicity has been recently reported for FMDV C-S8c1
in cell culture (Baranowski et al., 2000a, 2001) and in vivo
(Taboga et al., 1997; Nu´n˜ez et al., 2001). The observations
with FLAG-FMDV have also illustrated that coevolution of
antigenicity and cell tropism can come about not only
through the overlap between antibody- and receptor-
binding sites, but also through dispensability of an anti-
genic site due to loss of receptor function and the effect
that modification in such a site could exert on the stabil-
ity of other antigenic sites.
The possibility cannot be excluded that in addition to
the antigenic changes found in components of the mu-
tant spectrum, mutations in the consensus nucleotide
sequence elsewhere in the genome could also contrib-
ute to the fitness increase of O1K/p213Fp8 (Fig. 4). How-ever, the results document that mutations not found in
the consensus sequence can also contribute to fitness
increases. Recent analyses of virus populations in cell
culture and in vivo have provided evidence that a de-
tailed knowledge of the complexity of the mutant spec-
trum of evolving viral quasispecies can provide informa-
tion on the pathogenic potential of a virus (Rowe et al.,
1997; Forns et al., 1999; Farci et al., 2000), response to
reatment (Pawlotsky et al., 1998), and the past evolution-
ry history or potential outcome of virus evolution (Ruiz-
arabo et al., 2000; Arias et al., 2001). The present study
uggests that mutations found in the mutant spectrum
an also be indicative of the changes required in the
onmutated class of genomes (in our case coincident
ith the consensus sequence) for fitness increase.
MATERIALS AND METHODS
ells, viruses, infections, and biological cloning
The origin of BHK-21 cells has been previously de-
cribed (Sobrino et al., 1983). Cells were grown in Dul-
ecco’s modified Eagle’s medium (Gibco) supplemented
ith nonessential amino acids (Gibco) and 5% fetal calf
erum (Gibco).
FMDV C-S8c1 is a clone of natural isolate C-Sta Pau
p/70, a representative of the European subtype C1
iruses (Sobrino et al., 1983). FMDV C-S8c1p100 (Mar-
ı´nez et al., 1997) and C-S8c1p213 (Charpentier et al.,
996) are two viral populations resulting from 100 and
13 serial cytolytic passages of C-S8c1 in BHK-21 cells,
espectively (2 to 6 3 106 BHK-21 cells infected with 1 to
0 PFU per cell at each passage). Procedures for infec-
ions of cell monolayers and plaque assays with FMDV
ave been previously described (Sobrino et al., 1983;
Ruiz-Jarabo et al., 1999). For biological cloning, FMDV
was plated on cell monolayers under an agar overlay,
and virus clones were isolated from well-separated
plaques (Sobrino et al., 1983). FMDV single-step growth
curves were determined in BHK-21 cells, as previously
described (Baranowski et al., 2000b).
Antibodies and immunochemical assays
Site A-specific MAb SD6 (Mateu et al., 1989) was
raised against FMDV C-S8c1; it binds monovalently to
virus particles via a direct interaction with several resi-
dues of the VP1 G-H loop including the RGD (Verdaguer
et al., 1995, 1997). The anti-FLAG serum was kindly
provided by Rachael L. Neve; the serum was obtained by
inoculating rabbits with a synthetic octapeptide (se-
quence Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) (Prickett et
al., 1989).
Western blot assays were performed as previously
described with minor modifications (Mateu et al., 1987,
1988). Briefly, FMDV particles were concentrated by sed-
imentation through a sucrose cushion, and viral proteins
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199FMDV LACKING THE VP1 G-H LOOPwere quantified by densitometry of the Coomassie blue-
stained protein bands separated by SDS–PAGE in the
presence of 8 M urea (SDS–urea–PAGE). About 10 pmol
(VP1 equivalents) of FMDV particles were resolved by
SDS–urea–PAGE and transferred to a nitrocellulose
membrane using the Mini-Protean II and Mini-Trans-blot
transfer systems (Bio-Rad). Nonspecific binding of pro-
tein to the membrane was blocked by treatment with
either 5% nonfat milk or 2% bovine serum albumin before
incubation of the blots with specific monoclonal or poly-
clonal antibodies. The membranes were washed, ex-
posed to appropriate secondary antibodies conjugated
to horseradish peroxidase, and developed using an ECL
Western blotting detection system (Amersham), following
the manufacturer’s instructions.
Chimeric FMDVs, plasmid constructs, in vitro
transcription, and cell transfection
Chimeric FMDVs O1K/C-S8c1, O1K/p100, and O1K/
p213 were derived from full-length chimeric cDNAs of
FMDV O1K (Zibert et al., 1990) (Fig. 2). They encode the
capsid proteins of FMDV C-S8c1, C-S8c1p100, and
C-S8c1p213, respectively (Baranowski et al., 1998,
2000b). Chimeric cDNAs pO1K/C-S8c1F, pO1K/p100F,
and pO1K/p213F are new chimeric constructs that en-
code a FLAG marker (amino acid sequence DYKDDDDK)
(Prickett et al., 1989) that takes the place of amino acid
residues 139 to 146 (sequence SARGDLAH) in the VP1
G-H loop of C-S8c1, C-S8c1p100, and C-S8c1p213, re-
spectively (Fig. 2). For their construction, the FMDV
C-S8c1 genomic regions spanning nucleotides 2817 to
3621 (fragment 2817–3621) and 3646 to 4189 (fragment
3646–4189) were PCR-amplified from plasmid p3242/C-
S8c1 (Baranowski et al., 1998) using oligonucleotide
primers 59-CTTGGCCGGTTTGGCCCAGTAC-39 (sense)
nd 59-GCTTGTCATCGTCGTCCTTGTAGTCGGCGGTGTA-
GGTCGTAGTGC 39 (antisense), and 59-CTACAAGGACGA-
CGATGACAAGCTTACGACGACGCATGCTCGG-39 (sense)
and 59-CAAACGTGCTGTCCAGAATCTC-39 (antisense),
espectively; nucleotides corresponding to the FLAG-
oding sequence are underlined. Numbering of FMDV
enomic residues is according to Toja et al. (1999). The
esulting PCR products were assembled by shuffling
CR (Stemmer, 1994). Briefly, equimolar amounts of each
urified fragment were mixed and amplified by 5 cycles
f PCR in the absence of primers, followed by 30 cycles
n the presence of the oligonucleotides that hybridize
ith the 59-end of fragment 2817–3621 and the 39-end of
ragment 3646–4189. All PCR amplifications were carried
ut using a Pfu DNA polymerase (Promega), and PCR
roducts were separated by agarose gel electrophore-
is. The final amplification product spans FMDV genomic
esidues 2817 to 4189 and was used to substitute the
ssHII–AvrII fragment (FMDV genomic positions 3395 to
757, which encode the modified VP1 G-H loop) for theorresponding sequence in the full-length cDNAs of
MDV. Plasmids pO1K/p213FD143-145, pO1K/
p213FN142, pO1K/p213FK167, pO1K/p213FR200, and
pO1K/p213FK200 differ from pO1K/p213F by the pres-
ence of a deletion of VP1 codons 143 to 145 or point
mutations corresponding to single amino acid substitu-
tions D142 3 N, E167 3 K, Q200 3 R, or Q200 3 K,
respectively, in VP1. For their construction, the VP1 cap-
sid-coding region of FMDV clones derived from O1K/
p213Fp8 population (Fig. 5) was amplified by RT-PCR,
and the fragments encoding the indicated substitutions
were cloned into pO1K/p213F, using appropriate restric-
tion endonucleases.
In vitro transcription was performed as previously de-
scribed (Baranowski et al., 1998). RNA transcripts (1 mg)
were introduced into BHK-21 cells by electroporation
(Jackson et al., 1997). RNA from recombinant viruses
resulting from one round of replication after transfection
was retrotranscribed and the sequence encoding the
capsid proteins was analyzed. All recombinant viruses
maintained the expected nucleotide sequence identical
to that in the original plasmid constructions.
RNA extraction, RT-PCR amplification, and nucleotide
sequencing
RNA extraction, cDNA synthesis, and PCR amplifica-
tion (RT-PCR) were performed as previously described
(Escarmı´s et al., 1996). cDNAs and plasmids were se-
uenced either in an automated sequencer (ABI 373) or
sing the Thermo Sequenase cycle sequencing kit (Am-
rsham). The oligonucleotide primers used for RT-PCR
nd for nucleotide sequencing have been described
Baranowski et al., 1998).
Fitness assay
The relative fitness of FMDV populations was deter-
mined by growth-competition experiments with a refer-
ence virus (Holland et al., 1991; Duarte et al., 1992),
according to the procedure previously described (Escar-
mı´s et al., 1999). The viral populations to be tested and
the reference virus O1K/p213F were mixed at a PFU ratio
ranging from 1 to 0.1. BHK-21 cells (2 3 106) were infected
with the mixture at a m.o.i. of 0.1 PFU per cell. When the
cythopathic effect was nearly complete, the progeny vi-
rus was diluted 10-fold and used to infect a fresh cell
monolayer. RNA from virus at passage 0 (the initial mix-
ture) to passage 3 was isolated, RT-PCR amplified, and
sequenced using the Thermo Sequenase cycle sequenc-
ing kit (Amersham). The proportion of the two competing
viruses in the different passages was estimated by the
quantification of the marker mutation. Fitness values
were calculated as described (Escarmı´s et al., 1999).
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